[Long-term results of combined photon-neutron radiotherapy for malignant salivary gland tumors at the Ural Neutron Therapy Center].
An evaluation of combined photon-neutron radiotherapy (CPNT) of malignant tumors of the salivary gland (31) is presented. Overall 1-year survival was 100%, 2 years--95%, 3 years--65%, 4 years--57% and 5 years--47%. Radiation-related injury incidence did not vary dramatically: CPNT--15%, photon therapy--11%. Most relapse occurred within the first 24 months.
E Iu
EIu
Lukina
A V
AV
Vazhenin
A I
AI
Kuznetsova
Z Z
ZZ
Munasipov
G V
GV
Mokichev
G N
GN
Rykovanov
G G
GG
Bobkova
D000328:Adult; D000368:Aged; D002173:Cancer Care Facilities; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009502:Neutrons / Q000627:therapeutic use*; D017785:Photons / Q000627:therapeutic use*; D012426:Russia; D012468:Salivary Gland Neoplasms / Q000532:radiotherapy*; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome